• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Anal Cancer Companies

    ID: MRFR/MED/1001-HCR
    130 Pages
    Kinjoll Dey
    October 2025

    Several pharmaceutical and biotechnology companies are involved in the development of cancer therapies, including those targeting various types of cancers, such as anal cancer. Anal cancer is a relatively rare cancer that forms in the tissues of the anus. Treatments may include surgery, radiation therapy, and chemotherapy.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Anal Cancer Market Research Report - Forecast till 2032 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Anal Cancer Market

    Anal Cancer Companies

     


    Latest Anal Cancer Companies Updates:


    Oncolytics Biotech presented promising data at the ASH annual meeting regarding the combination of their drug pelareorep with the checkpoint inhibitor atezolizumab for advanced squamous cell carcinoma of the anus (SCCA). This could offer a new treatment option for this difficult-to-treat cancer.


    Bristol Myers Squibb showcased several research findings on blood disorders and cell therapy at the ASH meeting, including potential advancements in immunotherapy for anal cancer.Virtu Market Research reported a projected value of USD 669.24 million for the Global Rapid Diagnostic Testing for Anal Cancer Market by 2030, indicating continued growth in demand for fast and accurate diagnosis.


    List of Anal Cancer Key companies in the market:



    • Amgen Inc. (US)

    • Bristol-Myers Squibb Company (US)

    • Celgene Corporation (US)

    • Eli Lilly and Company (US)

    • F. Hoffmann-La Roche Ltd (Switzerland)

    • Merck & Co., Inc. (US)

    • Novartis AG (Switzerland)

    • Pfizer Inc. (US)

    • GlaxoSmithKline plc (UK)

    • Sanofi (France)